This HTML5 document contains 105 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n11http://dx.doi.org/10.1161/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q51022288
rdf:type
wikibase:Item
schema:description
bilimsel makale 2004년 논문 artigo científico article científic 2004年學術文章 teaduslik artikkel article scientific articolo scientifico επιστημονικό άρθρο 2004 nî lūn-bûn artikulong pang-agham บทความทางวิทยาศาสตร์ vitenskapelig artikkel 2004年學術文章 научни чланак 2004年学术文章 scienca artikolo article scientifique scientific article published on 23 February 2004 სამეცნიერო სტატია мақолаи илмӣ ২৩ ফেব্রুয়ারি ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ videnskabelig artikel מאמר מדעי artigo científico مقالة علمية نشرت في 23 فبراير 2004 научна статия wetenschappelijk artikel bài báo khoa học vědecký článek 2004年學術文章 vedecký článok 2004年の論文 2004年学术文章 tudományos cikk научни чланак vetenskaplig artikel 2004年学术文章 наукова стаття, опублікована в лютому 2004 artículu científicu 2004年学术文章 wissenschaftlicher Artikel scientific article published on 23 February 2004 articol științific tieteellinen artikkeli 2004年學術文章 artigo científico artykuł naukowy artikull shkencor научная статья naučni članak 2004年學術文章 vitskapeleg artikkel artículo científico publicado en 2004 2004年学术文章 artikel ilmiah scientific article published on 23 February 2004 2004年学术文章
p:P577
wds:Q51022288-7A340F50-911E-4810-9533-942BE9172ABE
wdt:P577
2004-02-23T00:00:00Z
p:P407
wds:Q51022288-3D1D7335-D39D-4574-8F1D-E8BDC090A4B1
wdt:P407
wd:Q1860
p:P2093
wds:Q51022288-2397FEF7-82DB-4222-A55B-355B4E4D29BC wds:Q51022288-E27060E3-287E-481D-A92B-5D5166C5163A wds:Q51022288-CACD832D-9CCE-48F9-8808-D98E72C1B7BF wds:Q51022288-C7656410-2C3B-47E0-8BA6-10C8FB987823 wds:Q51022288-820B934B-16D6-4D8E-880F-BAC05F432601 wds:Q51022288-56CBE1C7-C66D-4AAB-A473-FFD8075835DD
wdt:P2093
David J Webb Neil R Johnston Allan D Cumming Malcolm F Hand Jane Goddard Andrew J Rankin
rdfs:label
Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.
skos:prefLabel
Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.
schema:name
Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.
p:P50
wds:Q51022288-0353248F-CCD1-4E8E-B74F-340285AE9752
wdt:P50
wd:Q40341003
p:P1476
wds:Q51022288-800B13EE-8AD9-45E4-87C3-9C858F783671
wdt:P1476
Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.
p:P304
wds:Q51022288-A04EF22C-116F-4974-8FAD-86B7167BFD57
wdt:P304
1186-1193
p:P31
wds:Q51022288-4C6D2D0C-8B1D-46F6-B892-E77C97AE81CE
wdt:P31
wd:Q13442814
p:P921
wds:Q51022288-6F3DC06D-7CE0-4F38-8370-BAB89EB7D88D
wdt:P921
wd:Q181600
p:P698
wds:Q51022288-7FACDD2B-7F3A-4564-A9A3-0D1136AF9666
wdtn:P698
n12:14981006
wdt:P698
14981006
p:P1433
wds:Q51022288-F4CD08FA-B512-409C-AFAC-283EC5662125
wdt:P1433
wd:Q578091
p:P433
wds:Q51022288-D057F580-ED29-484A-A74C-F6D4FB6E044A
p:P478
wds:Q51022288-1BD37847-B4D2-4CB6-9FC6-E85656EDFD66
wdt:P433
9
wdt:P478
109
p:P356
wds:Q51022288-D7B09481-A7A7-4B2A-A9AD-9D64C1950991
wdtn:P356
n11:01.CIR.0000118499.69469.51
wdt:P356
10.1161/01.CIR.0000118499.69469.51
p:P5875
wds:Q51022288-EBC381CA-9902-4459-BE97-BB859ADB37DD
wdt:P5875
8257337